• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Immunogen Inc (NQ: IMGN )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EST, Feb 9, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open -
    Bid (Size) 31.23 (2,500)
    Ask (Size) 31.25 (400)
    Prev. Close 31.25
    Today's Range N/A - N/A
    52wk Range 13.83 - 31.24
    Shares Outstanding 266,264,274
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    3 Unstoppable Mega-Cap Stocks That Every Investor Should Own in 2024
    Dive into the world of three unstoppable mega-cap stocks leading the charge amidst the bullishness in the market. 
    Via InvestorPlace
    Amicus Therapeutics Stock Sees Improved Relative Strength Rating
    In a welcome move, Amicus Therapeutics stock saw its Relative Strength Rating rise from 64 to 78 on Friday. 
    Via Investor's Business Daily

    Performance

    More News

    Read More
    ImmunoGen Inc. (NASDAQ: IMGN) Near Top of Volume Charts in Thursday Trading
    Via Investor Brand Network
    3 Strong Buy Biotech Stocks to Add to Your February Must-Watch List
    Via InvestorPlace
    7 Russell 2000 Stocks to Buy for the Next Bull Run: February 2024
    Via InvestorPlace
    Madrigal Pharmaceuticals Stock Shows Rising Relative Strength
    Via Investor's Business Daily
    AbbVie Lifts Long-Term Outlook For New Immunology Drugs, Even As Q4 Revenue and Profit Fall
    Via Benzinga
    ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From ImmunoGen, Inc.
    Via Business Wire
    Investors Take Note as Corbus Pharma Releases Data for ADC Tumor Candidate
    Via Get News
    Exposures Product Safety
    AbbVie's Transformational 2023, Analyst Anticipates Growth in 2024 Amid Competitive Pressures
    Via Benzinga
    Investors Take Note as Corbus Pharma Releases Data for ADC Tumor Candidate
    Via News Direct
    Investors Take Note as Corbus Pharma Releases Data for ADC Tumor Candidate
    Via TheNewswire.com
    Exposures Product Safety
    ABBV: This Top Biotech Just Went On A Buying Spree
    Via Talk Markets
    Axsome Therapeutics Stock Showing Leadership, Earns 91 RS Rating
    Via Investor's Business Daily
    7 Dividend Aristocrats That Will Pay You for Years to Come
    Via InvestorPlace
    Ultragenyx Pharm Stock Earns IBD Stock Upgrade With RS Rating Jump To 83
    Via Investor's Business Daily
    Cassava Sciences Stock Continues Showing Rising Relative Strength
    Via Investor's Business Daily
    Cramer Says This Major Healthcare Stock Is 'Ridiculously Cheap And Doing So Many Great Things'
    Via Benzinga
    Is AbbVie Stock a Buy Now?
    Via The Motley Fool
    Topics Intellectual Property
    Exposures Intellectual Property
    Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024
    Via Investor's Business Daily
    ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From ImmunoGen, Inc.
    Via Business Wire
    3 Biotech Stocks Set for Breakthroughs in 2024
    Via InvestorPlace
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    Bristol Myers Squibb’s big buys: $18.1 billion in 2 biotech deals
    Via MarketBeat
    Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.